Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tepotinib
tepotinib
Merck KGaA’s targeted lung cancer drug tepotinib wins early access in UK
Pharmaforum
Thu, 07/15/21 - 12:29 pm
Merck KGaA
lung cancer
UK
tepotinib
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
Pharmaforum
Wed, 08/26/20 - 11:03 am
Merck KGaA
MET inhibitors
tepotinib
lung cancer
In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug
Endpoints
Wed, 03/25/20 - 10:45 am
Novartis
Merck KGaA
Japan
tepotinib
non-small cell lung cancer
Merck KGaA nabs FDA “Breakthrough” tag for MET-targeting lung cancer drug
Pharmaforum
Wed, 09/11/19 - 11:48 pm
FDA
Merck KGaA
MET
lung cancer
tepotinib
non-small cell lung cancer